BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. ✅
Go to Publication ✅
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , |
|
|
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Additional sources and private correspondance ✅
Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12 Pub: 2018 Epub: |
|
|
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 100 Issue 6 Pages: 1324-32 Pub: 2006 Jun Epub: Authors Hütt P , Shchepetova J , Lõivukene K , Kullisaar T , Mikelsaar M , |
|
|
Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 12 Issue 4 Pages: e0175935 Pub: 2017 Epub: 2017 Apr 24 Authors Celiberto LS , Bedani R , Dejani NN , Ivo de Medeiros A , Sampaio Zuanon JA , Spolidorio LC , Tallarico Adorno MA , Amâncio Varesche MB , Carrilho Galvão F , Valentini SR , Font de Valdez G , Rossi EA , Cavallini DCU , |
|
|
Bifidobacterium longum subsp. longum 51A attenuates intestinal injury against irinotecan-induced mucositis in mice. ✅
Go to Publication ✅
Life sciences (Life Sci ) Vol: 289 Issue Pages: 120243 Pub: 2022 Jan 15 Epub: 2021 Dec 16 Authors Quintanilha MF , Miranda VC , Souza RO , Gallotti B , Cruz C , Santos EA , Alvarez-Leite JI , Jesus LCL , Azevedo V , Trindade LM , Cardoso VN , Ferreira E , Carvalho BA , Soares PMG , Vieira AT , Nicoli JR , Martins FS , |
|
|
Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 6 Pages: Pub: 2023 Mar 21 Epub: 2023 Mar 21 Authors De Oliveira FL , Salgaço MK , de Oliveira MT , Mesa V , Sartoratto A , Peregrino AM , Ramos WS , Sivieri K , |
|
|
Bifidobacterium longum subsp. longum BL21 Ameliorates Alcoholic Liver Disease in Mice Through Enhancement of the Hepatic Antioxidant Capacity and Modulation of the Gut Microbiota. ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: Issue Pages: Pub: 2023 Oct 31 Epub: 2023 Oct 31 Authors Dong Y , Wu Z , Gai Z , Han M , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
Bifidobacterium longum S3 alleviates loperamide-induced constipation by modulating intestinal acetic acid and stearic acid levels in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6118-6133 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Zhang T , Lu H , Cheng T , Wang L , Wang G , Zhang H , Chen W , |
|
|
A methyl esterase from Bifidobacterium longum subsp. longum reshapes the prebiotic properties of apple pectin by triggering differential modulatory capacity in faecal cultures. ✅
Go to Publication ✅
Microbial biotechnology (Microb Biotechnol ) Vol: 17 Issue 5 Pages: e14443 Pub: 2024 May Epub: Authors Calvete-Torre I , Sabater C , Muñoz-Almagro N , Campelo AB , Moreno FJ , Margolles A , Ruiz L , |
|
|
Bifidobacterium longum GL001 alleviates rat intestinal ischemia-reperfusion injury by modulating gut microbiota composition and intestinal tissue metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3653-3668 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Tang J , Zhao M , Miao X , Chen H , Zhao B , Wang Y , Guo Y , Wang T , Cheng X , Ruan H , Zhang J , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 19 Pages: Pub: 2023 Sep 22 Epub: 2023 Sep 22 Authors Kou R , Wang J , Li A , Wang Y , Zhang B , Liu J , Sun Y , Wang S , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-?B and MAPK Signaling Pathways In Vivo. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 23 Pages: 8915-8930 Pub: 2023 Jun 14 Epub: 2023 May 31 Authors Yue Y , Wang Y , Xie Q , Lv X , Zhou L , Smith EE , Cao T , Zhang Y , Li B , Huo G , Ma W , |
|
|
Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice. ✅
Go to Publication ✅
Journal of inflammation research (J Inflamm Res ) Vol: 16 Issue Pages: 1393-1404 Pub: 2023 Epub: 2023 Mar 27 Authors Fitri LE , Sardjono TW , Winaris N , Pawestri AR , Endharti AT , Norahmawati E , Handayani D , Kurniawan SN , Azizah S , Alifia LI , Asiyah R , Ayuningtyas TR , |
|
|
Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 1 Pages: Pub: 2022 Dec 22 Epub: 2022 Dec 22 Authors Shi S , Zhang Q , Sang Y , Ge S , Wang Q , Wang R , He J , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 19 Pages: 9947-9958 Pub: 2022 Oct 3 Epub: 2022 Oct 3 Authors Hao J , Zhang Y , Wu T , Liu R , Sui W , Zhu J , Fang S , Geng J , Zhang M , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 955112 Pub: 2022 Epub: 2022 Aug 5 Authors Hu Y , Jin X , Gao F , Lin T , Zhu H , Hou X , Yin Y , Kan S , Chen D , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 902337 Pub: 2022 Epub: 2022 Aug 1 Authors Xiao F , Dong F , Li X , Li Y , Yu G , Liu Z , Wang Y , Zhang T , |
|
|
Recombinant Bifidobacterium longum Carrying Endostatin Protein Alleviates Dextran Sodium Sulfate-Induced Colitis and Colon Cancer in Rats. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 927277 Pub: 2022 Epub: 2022 Jun 30 Authors Bi Z , Cui E , Yao Y , Chang X , Wang X , Zhang Y , Xu GX , Zhuang H , Hua ZC , |
|
|
Bifidobacterium longum CCFM752 prevented hypertension and aortic lesion, improved antioxidative ability, and regulated the gut microbiome in spontaneously hypertensive rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 11 Pages: 6373-6386 Pub: 2022 Jun 6 Epub: 2022 Jun 6 Authors Lu W , Wang Y , Fang Z , Wang H , Zhu J , Zhai Q , Zhao J , Zhang H , Chen W , |
|
|
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , |
|
|
Different Alterations in Gut Microbiota between Bifidobacterium longum and Fecal Microbiota Transplantation Treatments in Propionic Acid Rat Model of Autism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 14 Issue 3 Pages: Pub: 2022 Jan 30 Epub: 2022 Jan 30 Authors Abujamel TS , Al-Otaibi NM , Abuaish S , AlHarbi RH , Assas MB , Alzahrani SA , Alotaibi SM , El-Ansary A , Aabed K , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
Bifidobacterium longum-fermented rice bran and rice bran supplementation affects the gut microbiome and metabolome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 10 Issue 8 Pages: 823-839 Pub: 2019 Dec 9 Epub: 2019 Sep 29 Authors Nealon NJ , Parker KD , Lahaie P , Ibrahim H , Maurya AK , Raina K , Ryan EP , |
|
|
In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 120 Issue Pages: 595-602 Pub: 2019 Jun Epub: 2018 Nov 9 Authors Bianchi F , Larsen N , Tieghi TM , Adorno MAT , Saad SMI , Jespersen L , Sivieri K , |
|
|
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 10 Issue 3 Pages: 1595-1608 Pub: 2019 Mar 20 Epub: Authors Yan S , Yang B , Zhao J , Zhao J , Stanton C , Ross RP , Zhang H , Chen W , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Bifidobacterium longumBL-19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 9 Pages: 6442-6460 Pub: 2024 Sep Epub: 2024 Jun 18 Authors Zhang X , Xu J , Dong X , Tang J , Xie Y , Yang J , Zou L , Wu L , Fan J , |
|
|
Bifidobacterium longum supplementation prevents intestinal inflammation and cognitive impairment in sleep-deprived mice by modulating clock gene expression. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2025 Nov 10 Epub: 2025 Nov 10 Authors Huang L , Li X , Guo M , Lu W , Zhao J , Xiao Y , Chen W , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
